how much allulose to trigger glp-1 Release by Rare Sugar D-Allulose Ameliorates Sucrose-Induced Obesity and Glucose Intolerance in Ovariectomized Mice Is Allulose a GLP-1 Agonist?
Description
Side effects what to expect The most common side effects are gastrointestinal and worst in the first 48 weeks (full breakdown in our side-effects guide): Nausea (around 40% of patients in week one usually settles) Constipation or diarrhoea Reflux / burping / "sulphur burps" Reduced appetite (the desired effect) Tiredness and dizziness especially if dehydrated Less common but more serious risks include pancreatitis, gallbladder disease, severe dehydration leading to acute kidney injury, and very rarely thyroid C-cell tumours (seen in rodents human relevance unclear, but the medicines are contraindicated in MEN2 and personal/family history of medullary thyroid cancer)
Current research indicates that GLP-1RAs may offer therapeutic benefits beyond their established use in obesity and type 2 diabetes management
That is why so many people hit a wall
Causes of death in women with breast cancer: a risks and rates study on a population-based cohort
